<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

AOFAS 2019: Arthrosurface’s New BOSS Toe Fixation System

Posted by Natasha Weeks on 10/16/19 10:00 AM

SmartTRAK Interviews Carl Hasselman, MD about Arthrosurface’s alternative to toe fusions

Arthrosurface showcased its new BOSS Toe Fixation System at the American Orthopaedic Foot & Ankle Society’s (AOFAS 2019) Annual Meeting held September 11–15 in Chicago, IL. Recently 510k cleared, the system improves stabilization in a first metatarsal with a distal bone void. The Boss Toe Screw fills the current product gap in implant solutions for failed synthetic implants. The system provides an option for patients who want to avoid a toe fusion while regaining motion and enjoying an active lifestyle.

To find out more about the new BOSS Toe Fixation System, its benefits, and how it fits in Arthrosurface’s existing line of HemiCAP DF implants and ToeMotion Systems, SmartTRAK interviewed Carl Hasselman, MD, University of Pittsburgh Medical Center, at AOFAS 2019.

To listen to SmartTRAK’s interview with Dr. Hasselman, click on the following video (11:14 minutes). A transcript of the interview is also provided below.

Read More

Topics: Orthopedics

Q219 CAS Spine Market Recap: Competition Ramping Up

Posted by Elise Wolf on 9/26/19 10:00 AM

Expanding Applications and New Robotic Launches on the Horizon

Enabling technologies in spine surgery continued to gain market acceptance in Q219 given benefits including lower revision rates, ability to market to patients and ability to plan the surgery beforehand, bolstered by several presentations on the benefits of computer-assisted spine surgery at the International Society for Computer-Assisted Orthopaedic Surgery (CAOS) meeting, held in New York City in June. While questions on long-term clinical benefits associated with robotic-assisted surgery remain, CAOS President, Dr. Patrick Meere, believes robotics in spine and orthopedics will continue to gain traction. In SmartTRAK’s interview with Dr. Meere in the article “CAOS 2019: A Synergy of Advanced Technologies,” he noted, “There is not a single venture in the medical field where robotic technologies entered and exited. They have always persisted. There may well be a lag, there may be naysayers, and there may be ...

Among the many topics covered in the complete Q219 CAS Spine Market Recap* are:

Read More

Topics: Orthopedics

Before OTA, Read SmartTRAK's Q219 Trauma Report

Posted by Natasha Weeks on 9/23/19 12:20 PM

Trauma segment experiences slight sequential gains as product intros gain traction and companies overcome supply disruption.

The WW Trauma Market ended Q2 posting +1.5% (reported) growth, with the US Market driving growth up 3.6% YOY, slightly up sequentially compared to Q1’s 3.2% gains. Internationally, Europe and ROW fared worse due to missed tenders, with -2.1% and -1.1% growth, respectively. Looking forward, SmartTRAK anticipates the trauma segment will see...

Among the many topics covered in the complete Q219 Trauma Market Recap* are:

Read More

Topics: Orthopedics

H119 Soft Tissue Fixation Market Recap: Solid Growth

Posted by Kristina Meyer on 9/19/19 10:16 AM

Strategy and focus in Sports Medicine for H119

Looking back on the first half of 2019, SmartTRAK reported solid growth, +3.9% in the US and +3.2% WW, across the board in the Soft Tissue Fixation Market. After several years of acquisitions within the Sports Medicine Market, the major players are all able to boast about well-rounded portfolios and the ability to compete in a majority of the Sports Medicine subspecialties. Subspecialty focus, strategy and shifts in market share are now becoming the keys to success in this market. Industry meetings such as American Association of Orthopedic Surgeons (AAOS), Arthroscopy Association of North America (AANA) and American Orthopaedic Society for Sports Medicine (AOSSM) revealed...

Among the many topics covered in the H119 Soft Tissue Fixation Market Recap* are:

Read More

Topics: Orthopedics

Q219 OrthoBio Market Recap: Strong Performance

Posted by Kim French on 9/12/19 10:00 AM

Sales strategy, market reach and evidence-based medicine drives strong Orthobiologics performance

SmartTRAK reports that Q219 performance in the OrthoBio market was strong, up 6% YoY, exceeding SmartTRAK expectations. As expected, Medtronic was the overall OrthoBio market leader, followed by DePuy Synthes and Stryker. Overall, all OrthoBio technologies grew year-over-year except for Spinal Constructs, Soft Tissue Augmentation and Synthetic Cartilage. Although the Spine market has stabilized, Spinal Constructs continues to slowly lose share due to...

Among the many topics covered in the Q219 OrthoBio Market Recap* are:

Read More

Topics: Orthopedics

Q219 Extremities Market Recap: Growth Slows

Posted by Lisa Mahan on 9/11/19 9:58 AM

Tough YoY comps, delays and salesforce disruptions slows growth

The WW Market for Foot & Ankle Fixation was up +2.0%, as reported, during Q219, although down sequentially due to tough YoY comps. The US Foot & Ankle Fixation market also experienced a sequential decline in growth. The historically strong segment faced extremely tough YoY comparisons along with no new product launches to spur growth. H119 US growth of...

Among the many topics covered in the Q219 Extremities Market Recap* are:

Read More

Topics: Orthopedics

Ahead of OTA, Top Trauma Trends for 2019

Posted by Lindsey Wolejko on 9/9/19 10:00 AM

Ahead of the Orthopedic Trauma Association (OTA) meeting, see what SmartTRAK’s Senior Analyst for Trauma & Extremities, Natasha Weeks, has to say about the latest trends in Trauma.

Natasha recently wrote a fascinating and informative article, " Trauma: Top Trends to Watch in 2019 and Beyond", in which she took a look back at 2018 and identified continuing and emerging trauma trends in the market that are likely to shape the landscape in 2019 and beyond. If you would like to download the article and discover SmartTRAK’s predictions for the top trauma market trends to watch, just click the button below.

Download the "Trauma: Top Trends to Watch" Article

Read More

Topics: SmartTRAK News, Orthopedics

Q219 Total Joints Market Recap: Hips Drive Acceleration

Posted by Lisa Mahan on 8/26/19 1:01 PM

Hips drive slight acceleration in TJR Market while Knees held steady

With two earnings seasons of 2019 behind us, US Total Joints Market growth of 1.7% for H119, as modeled by SmartTRAK Financial Dashboard, is trending below SmartTRAK projections of 2.6% growth for FY19. This trend is not surprising considering the heightened seasonality we’ve seen over the last few years in H2 due to high patient deductibles. US Total Joints Market growth strengthened slightly to 1.8% for Q219 compared to 1.6% in Q1 driven by...

Among the many topics covered in the Q219 Total Joints Market Recap* are:

Read More

Topics: Orthopedics

Join SmartTRAK, DSM and MCRA for Breakfast with an Executive Panel Discussion

Posted by Lindsey Wolejko on 8/20/19 7:59 PM

Join SmartTRAK for breakfast and an Executive Panel on “Advanced Technologies: Shifts in the Spine Landscape” at McCormick Place in Chicago, IL on Sept 26th. A panel of experts will be on hand to discuss the latest in advanced technologies, interbody devices, materials and design, and the impact these changes pose from an FDA regulatory standpoint.

Date:              Thursday, September 26th, 2019
Time:              7:30am-8:30am
Location:      Hyatt Regency McCormick Place,  Chicago, IL
Room:            Jackson Park C&D

Panelists include:

Read More

Topics: SmartTRAK News, Orthopedics

Q219 US Joint Fluid Market Recap: Marginal Revenue Growth

Posted by Freddy Buntoum on 8/12/19 8:55 AM

Q219 saw marginal revenue growth amid single-injection momentum and competitive pricing pressure

The numbers are in and now that we are in the second quarter of 2019, the US Joint Fluid market seems to be getting off its slow-ish start of the year, gaining some momentum with the single-injection segment pushing the aggregate total revenue into positive growth, according to the recently published SmartTRAK Financial Dashboard. This, despite relentless and fierce pricing competition in the multi-injection arena. 

Among the many topics covered in the Q219 US Joint Fluid Market Recap* are:

Read More

Topics: Orthopedics

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts